{
  "compound": "CBD",
  "condition": "ARTHRITIS",
  "effect_size": "N/A (safety study)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:ARTHRITIS_OBSERVATIONAL_012",
  "participants": "284 RA patients on concurrent CBD + methotrexate therapy",
  "year": 2020,
  "notes": "Cannabidiol and Methotrexate Drug-Drug Interaction Study in Rheumatoid Arthritis",
  "confidence": "medium",
  "abstract": "No clinically significant pharmacokinetic interaction detected; MTX efficacy maintained; CBD efficacy maintained; no increased hepatotoxicity; liver enzymes stable"
}